Joint Formulary & PAD

Clascoterone - Acne

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

See narrative
Formulations :
  • Cream
Associated Icons :
NFD2
SPC
Restrictions / Comments :

This drug has not yet been assessed for formulary status.
It has not yet been evaluated by NICE or the Surrey Heartlands ICS Area Prescribing Committee (APC). As such, advice regarding safety, effectiveness (including cost-effectiveness) and its place in therapy is yet to be determined. 
Before prescribing this drug it is recommended that clinicians contact their Medicines Optimisation team to discuss possible alternatives/options.

NICE are due to publish guidance on this drug - date to be confirmed. This will be considered by the APC within 90 days of publication.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Clascoterone
Indication :
Acne
Group Name :
Keywords :
Acne vulgaris
Brand Names Include :
Winlevi
Important Information :

Acne vulgaris. Not assessed for inclusion on formulary. NICE publication date to be confirmed. 

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Clascoterone is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Acne.

Committee Recommendations (0)

  • No records returned.